Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Laurence W. Lytton currently holds 2,926,957 shares of HTG MOLECULAR DIAGNOSTICS, INC (HTGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laurence W. Lytton has been a net buyer of HTGM stock. They have purchased $1.4M and sold $22.7K worth of shares.
Laurence W. Lytton's most recent insider trade was on May 13, 2022, when they purchased 1,375,000 shares at $0.50 per share.
Laurence W. Lytton serves as Executive at HTG MOLECULAR DIAGNOSTICS, INC (HTGM). They have executed 20 insider transactions totaling $1.5M over their tenure at the company.
Laurence W. Lytton holds the position of Executive at HTG MOLECULAR DIAGNOSTICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Laurence W. Lytton has shown a buying trading pattern, with $1.4M in total purchases and $22.7K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Laurence W. Lytton was on May 13, 2022, when they purchased $687.5K worth of LIQT shares. This transaction involved 1,375,000 shares at $0.50 per share.
Laurence W. Lytton currently owns 2,926,957 shares of HTG MOLECULAR DIAGNOSTICS, INC (HTGM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Laurence W. Lytton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Laurence W. Lytton has 20 Form 4 filings on record as an insider at HTG MOLECULAR DIAGNOSTICS, INC.
Set alerts for Laurence W. Lytton and 40,000+ other insiders.